Tuttle Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Tuttle Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$207.01 - $276.09 $411,121 - $548,314	-1,986 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $242,611 - $287,641	949 Added 91.51%	1,986 $540,000
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $233,822 - $306,744	1,037 New	1,037 $301,000
Q2 2019 Jul 29, 2019	SELL	$164.61 - $190.37 $432,430 - $500,101	-2,627 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $430,118 - $511,476	2,627 New	2,627 $483,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Tuttle Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tuttle Capital Management, LLC with notifications on news.